Literature DB >> 29679621

The global burden of hyperglycemia in pregnancy - Trends from studies in the last decade.

Bhuvan Martin1, David A Sacks2.   

Abstract

Concurrent with the rise in obesity, global rates of diabetes are increasing at alarming rates in both developed and developing nations. As these conditions become more prevalent among women of reproductive age, rates of hyperglycemia in pregnancy (HIP) are also increasing. HIP is associated with many immediate perinatal complications which affect both maternal and fetal/neonatal health, as well as with more long term complications. Long term complications include an increase in chronic non-communicable diseases in both mother and offspring, therefore affecting future generations. In addition to these health burdens, pregnancies complicated by hyperglycemia are also associated with greater economic costs. It is therefore imperative to allocate educational and health care dollars and resources to decelerate the increasing prevalence of diabetes and HIP.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29679621     DOI: 10.1016/j.diabres.2018.04.003

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  8 in total

Review 1.  Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy.

Authors:  David H Abbott; Daniel A Dumesic; Jon E Levine
Journal:  Expert Rev Endocrinol Metab       Date:  2019-02-15

2.  Effects of obesity and a history of gestational diabetes on the risk of postpartum diabetes and hyperglycemia in Chinese women: Obesity, GDM and diabetes risk.

Authors:  Yuxin Fan; Weiqin Li; Huikun Liu; Leishen Wang; Shuang Zhang; Wei Li; Hongyan Liu; Junhong Leng; Yun Shen; Jaakko Tuomilehto; Zhijie Yu; Xilin Yang; Ming Liu; Gang Hu
Journal:  Diabetes Res Clin Pract       Date:  2019-08-28       Impact factor: 5.602

Review 3.  In utero Androgen Excess: A Developmental Commonality Preceding Polycystic Ovary Syndrome?

Authors:  David H Abbott; Marissa Kraynak; Daniel A Dumesic; Jon E Levine
Journal:  Front Horm Res       Date:  2019-09-09       Impact factor: 2.606

4.  Experiences of lifestyle change among women with gestational diabetes mellitus (GDM): A behavioural diagnosis using the COM-B model in a low-income setting.

Authors:  Lorrein Shamiso Muhwava; Katherine Murphy; Christina Zarowsky; Naomi Levitt
Journal:  PLoS One       Date:  2019-11-25       Impact factor: 3.240

5.  Tripeptide Leu-Pro-Phe from Corn Protein Hydrolysates Attenuates Hyperglycemia-Induced Neural Tube Defect in Chicken Embryos.

Authors:  Chang-Yu Yan; Jie Sun; Gui-Yuan Yu; Jiang-Han-Zi Liu; Rong-Ping Huang; Shao-Cong Han; Qiong-Yi Zhang; Xiao-Min Li; Jian-Gang Yan; Hiroshi Kurihara; Wei-Xi Li; Yi-Fang Li; Rong-Rong He
Journal:  Oxid Med Cell Longev       Date:  2022-08-29       Impact factor: 7.310

Review 6.  Naturally Occurring and Experimentally Induced Rhesus Macaque Models for Polycystic Ovary Syndrome: Translational Gateways to Clinical Application.

Authors:  David H Abbott; Jeffrey Rogers; Daniel A Dumesic; Jon E Levine
Journal:  Med Sci (Basel)       Date:  2019-11-27

7.  An Innovative Artificial Intelligence-Based App for the Diagnosis of Gestational Diabetes Mellitus (GDM-AI): Development Study.

Authors:  Jiayi Shen; Jiebin Chen; Zequan Zheng; Jiabin Zheng; Zherui Liu; Jian Song; Sum Yi Wong; Xiaoling Wang; Mengqi Huang; Po-Han Fang; Bangsheng Jiang; Winghei Tsang; Zonglin He; Taoran Liu; Babatunde Akinwunmi; Chi Chiu Wang; Casper J P Zhang; Jian Huang; Wai-Kit Ming
Journal:  J Med Internet Res       Date:  2020-09-15       Impact factor: 5.428

8.  Women's perspectives on motivational factors for lifestyle changes after gestational diabetes and implications for diabetes prevention interventions.

Authors:  Lisbeth Ørtenblad; Diana Høtoft; Rubab H Krogh; Vibeke Lynggaard; Jens Juel Christiansen; Claus Vinther Nielsen; Anne-Mette Hedeager Momsen
Journal:  Endocrinol Diabetes Metab       Date:  2021-03-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.